Abstract
Purpose. The intracellular delivery of functionally active proteins represents an important emerging strategy for laboratory investigation and therapeutic applications. Although a number of promising approaches for protein delivery have been developed, thus far there has been no attempt to compare the merits of the various delivery technologies. This issue is addressed in the current study.
Methods. In this study we utilize a sensitive luciferase reporter gene assay to provide unambiguous and quantitative evaluation of several strategies for the intracellular delivery of a biologically active protein comprised of the Gal4 DNA binding domain and the VP16 transactivating domain.
Results. Both a cationic lipid supramolecular complex and a polymeric complex were able to effectively deliver the chimeric transcription factor to cultured cells. In addition, protein chimeras containing the Tat cell penetrating peptide, but not those containing the VP22 peptide, were somewhat effective in delivery.
Conclusions. Both supramolecular protein-carrier complexes and protein chimeras with certain cell penetrating peptides can support intracellular delivery of proteins. In the cell culture setting the supramolecular complexes are more effective, but their large size may present problems for in vivo applications.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
S. R. Schwarze and S. F. Dowdy. In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol. Sci. 21:45–48 (2000).
M. Lindgren, M. Hallbrink, A. Prochiantz, and U. Langel. Cell-penetrating peptides. Trends Pharmacol. Sci. 21:99–103 (2000).
E. Vives, P. Brodin, and B. Lebleu. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272:16010–16017 (1997).
M. A. Chellaiah, N. Soga, S. Swanson, S. McAllister, U. Alvarez, D. Wang, S. F. Dowdy, and K. A. Hruska. Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J. Biol. Chem. 275:11993–12002 (2000).
N. A. Lissy, P. K. Davis, M. Irwin, W. G. Kaelin, and S. F. Dowdy. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature 407:642–645 (2000).
A. M. Vocero-Akbani, N. V. Heyden, N. A. Lissy, L. Ratner, and S. F. Dowdy. Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein. Nat. Med. 5:29–33 (1999).
S. R. Schwarze, A. Ho, A. Vocero-Akbani, and S. F. Dowdy. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285:1569–1572 (1999).
G. Elliott and P. O'Hare. Intercellular trafficking and protein delivery by a herpes virus structural protein. Cell 88:223–233 (1997).
A. Phelan, G. Elliott, and P. O'Hare. Intercellular delivery of functional p53 by the herpes virus protein VP22. Nat. Biotechnol. 16:440–443 (1998).
M. S. Dilber, A. Phelan, A. Aints, A. J. Mohamed, G. Elliott, C. I. Smith, and P. O'Hare. Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22. Gene Ther. 6:12–21 (1999).
B. Fang, B. Xu, P. Koch, and J. A. Roth. Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells. Gene Ther. 5:1420–1424 (1998).
D. Derossi, S. Calvet, A. Trembleau, A. Brunissen, G. Chassaing, and A. Prochiantz. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J. Biol. Chem. 271:18188–18193 (1996).
M. Pooga, U. Soomets, M. Hallbrink, A. Valkna, K. Saar, K. Rezaei, U. Kahl, J. X. Hao, X. J. Xu, Z. Wiesenfeld-Hallin, T. Hokfelt, T. Bartfai, and U. Langel. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat. Biotechnol. 16:857–861 (1998).
A. Astriab-Fisher, D. S. Sergueev, M. Fisher, B. R. Shaw, and R. L. Juliano. Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates. Biochem. Pharmacol. 60:83–90 (2000).
S. Calvet, P. Doherty, and A. Prochiantz. Identification of a signaling pathway activated specifically in the somatodendritic compartment by a heparin sulfate that regulates dendrite growth. J. Neurosci. 18:9751–9765 (1998).
M. Rojas, J. P. Donahue, and Z. Tan. and Y. Z. Lin. Genetic engineering of proteins with cell membrane permeability. Nat. Biotechnol. 16:370–375 (1998).
M. Chang, L. Zhang, J. P. Tam, and E. Sanders-Bush. Dissecting G protein-coupled receptor signaling pathways with membrane-permeable blocking peptides. Endogenous 5-HT(2C) receptors in choroid plexus epithelial cells. J. Biol. Chem. 275:7021–7029 (2000).
J. Hawiger. Noninvasive intracellular delivery of functional peptides and proteins. Curr. Opin. Chem. Biol. 3:89–94 (1999).
X. H. Liu, J. C. Castelli, and R. J. Youle. Receptor-mediated uptake of an extracellular Bcl-x(L) fusion protein inhibits apoptosis. Proc. Natl. Acad. Sci. U.S.A. 96:9563–9567 (1999).
O. Zelphati, Y. Wang, S. Kitada, J. C. Reed, P. L. Felgner, and J. Corbeil. Intracellular delivery of proteins with a new lipidmediated delivery system. J. Biol. Chem. 276:35103–35110 (2001).
J. H. Tinsley, J. Hawker, and Y. Yuan. Efficient protein transfection of cultured coronary venular endothelial cells. Am. J. Physiol. 275:H1873–1878 (1998).
M. J. Poznansky and R. L. Juliano. Biologic approaches to the controlled delivery of drugs: a critical review. Pharmacol. Rev. 36:277–336 (1984).
Y. Xu and F. C. Szoka, Jr. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 35:5616–5623 (1996).
A. Prochiantz. Messenger proteins: homeoproteins, TAT and others. Curr. Opin. Cell Biol. 12:400–406 (2000).
S. R. Schwarze, K. A. Hruska, and S. F. Dowdy. Protein transduction: unrestricted delivery into all cells? Trends Cell Biol. 10:290–295 (2000).
A. Ho, S. R. Schwarze, S. J. Mermelstein, G. Waksman, and S. F. Dowdy. Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res. 61:474–477 (2001).
S. Futaki, T. Suzuki, W. Ohashi, T. Yagami, S. Tanaka, K. Ueda, and Y. Sugiura. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276:5836–5840 (2001).
J. D. Baleja, R. Marmorstein, S. C. Harrison, and G. Wagner. Solution structure of the DNA-binding domain of Cd2-GAL4 from S. cerevisiae. Nature 356:450–453 (1992).
P.M.Fischer, E. Krausz, and D.P. Lane. Cellular delivery of impermeable effector molecules in the form of conjugates with peptides capable of mediating membrane translocation. Bioconjugate Chem. 12:825–841 (2001).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ye, D., Xu, D., Singer, A.U. et al. Evaluation of Strategies for the Intracellular Delivery of Proteins. Pharm Res 19, 1302–1309 (2002). https://doi.org/10.1023/A:1020346607764
Issue Date:
DOI: https://doi.org/10.1023/A:1020346607764